AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
The stock of
(CORZ) has surged over 200% year-to-date, fueled by its pivot from cryptocurrency mining to AI infrastructure. This strategic repositioning has positioned the company at the epicenter of the AI compute boom, where rising demand for high-performance data centers is driving a valuation re-rating. Let's dissect why is primed to capitalize on this secular trend—and why investors should consider buying now.Core Scientific's transformation from a
miner to an AI colocation provider is now paying dividends. The company's Q2 2025 progress—delivering 8MW of billable capacity to CoreWeave by May 2025 and an additional ~40MW by the end of the quarter—marks a critical step toward its 250MW target by year-end. This expansion aligns with its $10.2 billion revenue commitment under a 12-year partnership with , a leading AI infrastructure firm.
The company's shift to high-margin colocation services is already reshaping its financials. While Q1 2025 revenue fell 55% to $79.5 million due to Bitcoin's post-halving slump, colocation revenue hit $8.6 million—up from $0 in the prior year. Crucially, non-GAAP colocation gross margins reached 8%, excluding power pass-through costs, signaling operational leverage as utilization scales.
Core Scientific's partnerships with AI heavyweights like CoreWeave and OpenAI (via CoreWeave's $11.9 billion deal with OpenAI) underscore its strategic advantage. The 590MW capacity target by 2027 positions the firm to capture demand from enterprises racing to deploy AI models. Analysts estimate that global AI compute spending could hit $150 billion annually by 2030, with data center operators like CORZ benefiting from recurring revenue models.
The company's path to profitability hinges on utilization rates. While Q2 2025 utilization data isn't explicitly disclosed, the delivery of 48MW by June 2025 suggests a rapid ramp-up. Analysts project that achieving 80%+ utilization across its 250MW capacity by 2026 could push colocation revenue to $360 million annually, with margins expanding to 15-20% as fixed costs are absorbed. This compares favorably to Q1's 5% gross margin, which included pass-through costs.
Despite the stock's recent rally, CORZ trades at a 30.4x EBITDA multiple, below peers like
(EQIX) at ~35x. This discount reflects execution risks, including tariff-driven cost pressures and Bitcoin's volatility. However, Core Scientific's $778.6 million cash balance provides a buffer, while its $5 billion market cap remains small enough to see outsized gains from incremental revenue.
Mitigants include CoreWeave's multi-year commitments, which lock in revenue visibility, and Core Scientific's focus on low-cost power regions (e.g., Texas) to offset inflation.
Core Scientific is a buy at current levels, with a 12-month price target of $12 (30% upside from $9.20). Analysts project $0.73 EPS by 2025, suggesting the stock is still undervalued relative to its growth trajectory. Investors should use dips below $8.50 to accumulate, with risks hedged by the company's liquidity and partnership strength.
In a world where AI compute is the new oil, Core Scientific's infrastructure is the refinery. With utilization rates climbing and contracts secured, this stock is set to deliver outsized returns as the AI boom accelerates.
Final Note: Monitor Q2 2025 utilization metrics and CoreWeave's capacity ramp in the coming quarters for confirmation of this bullish case.
Tracking the pulse of global finance, one headline at a time.

Dec.14 2025

Dec.14 2025

Dec.14 2025

Dec.14 2025

Dec.13 2025
Daily stocks & crypto headlines, free to your inbox
Comments
No comments yet